Top
Home ยป Chandrakant Lahariya
Chandrakant Lahariya
About the AuthorChandrakant Lahariya
Dr Chandrakant Lahariya is a general physician, infectious diseases specialist and vaccines expert. He can be reached at c.lahariya@gmail.com
    An isolation ward for COVID-19 patients is prepared in view of rising cases of coronavirus in some countries, in Kanpur, Monday, Dec. 26, 2022. (PTI Photo)(Opinion
    Chandrakant Lahariya | In 2023, let's try to make India a healthier...

    This is India's opportunity to bring health issues to the fore globally.

    2 Jan 2023 12:17 AM IST

    A health worker takes a swab sample from a resident to be tested for Covid-19 coronavirus in Jiayuguan, in Chinas northwestern Gansu province. (Photo by AFP) / China OUTOpinion
    Chandrakant Lahariya | Lesson from China's surge: Don't drop guard on...

    The surge in China has not changed anything in India and there is no need to change people-related approaches in the...

    24 Dec 2022 8:57 AM IST

    among all childhood vaccines, measles is one of the most effective vaccines and two shots of the measles vaccine to a child reduces the risk of disease that is close to negligible. (Representational Image/AP)Opinion
    Chandrakant Lahariya | Amid surge in measles cases, it's time to step...

    A measles vaccine has been available since 1963 and used in India's universal immunisation programme since 1985

    9 Dec 2022 12:00 AM IST

    A healthworker prepares an oxygen triage facility for COVID-19 patients as coronavirus cases surge, at Omandurar Government hospital in Chennai. (Photo: PTI)Opinion
    Chandrakant Lahariya | Covid virus hasn't gone, but risk now is very...

    A key question remains whether Covid-19 is still a cause of worry or not? The short answer is no

    11 Nov 2022 12:00 AM IST

    Tomato fever is not the official name of any disease. (Representational Image)Opinion
    Chandrakant Lahariya | As tomato fever' emerges, misinformation...

    It has become clear that what has been reported is not a new virus but rather a form of the hand, foot and mouth...

    8 Sept 2022 12:00 AM IST

    A healthcare worker administers a dose of the Covid-19 preventive vaccine to a student in the age group of 12 to 14 years, at a vaccination centre, in New Delhi. (Photo: PTI)Opinion
    Chandrakant Lahariya | At 75, time to focus on a healthier India@100

    While health has got a lot of attention in the pandemic period there is a need for health to continue to be a sustained...

    16 Aug 2022 12:15 AM IST

    Monkeypox is a zoonotic disease that spreads from animals to humans. It belongs to the family of smallpox viruses. (Photo: AP file photo)Opinion
    Chandrakant Lahariya | Monkeypox's challenge: It's also an opportunity

    As of now, the Central and state governments in India appear to be prepared for responding to the monkeypox emergence

    28 July 2022 2:20 AM IST

    Monkeypox is a zoonotic disease that spreads from animals to humans. It belongs to the family of smallpox viruses. (Photo: AP file photo)Opinion
    Chandrakant Lahariya | Can monkeypox' disease develop into a pandemic?

    In the ongoing monkeypox outbreak, it will not be surprising if one or more cases are reported from India as well

    17 Jun 2022 1:21 AM IST

    A health worker collects swab samples of residents for Covid-19 testing, in Gurugram. (PTI)Opinion
    Chandrakant Lahariya | Don't worry too much as Covid cases surge again

    Most of those tested positive are asymptomatic or mild symptomatic & had got themselves tested voluntarily, for travel...

    20 April 2022 12:38 AM IST

    Students wearing face masks attend a class at a school that was reopened after closure for months owing to coronavirus pandemic, in Amritsar, Thursday, Oct. 22, 2020. Schools are being opened as per guidelines issued in Unlock. 5. (PTI)Opinion
    Chandrakant Lahariya | A new worry: How we need to live with Covid' in...

    The daily new Covid-19 cases in the country have come down to around 4,000 to 5,000, the lowest in 22 months since May...

    14 March 2022 3:14 AM IST

    This image provided by Pfizer in October 2021 shows the companys COVID-19 Paxlovid pills. U.S. health regulators on Wednesday, Dec. 22, 2021 authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. (Pfizer via AP)Opinion
    Chandrakant Lahariya | FDA approval of Covid pill a sign of hope for...

    The US Food and Drugs Administration approved an oral Covid-19 drug Paxlovid. Molnupiravir, too, received emergency...

    24 Dec 2021 12:27 AM IST

    All children in primary schools need personalised guidance from their teachers. (PTI Photo)Opinion
    Chandrakant Lahariya | Why primary schools should be the first to...

    The individual benefits are in terms of better jobs and increased family earning in the future

    1 Sept 2021 1:52 AM IST

    X